ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 650

Genome-Wide DNA Methylation, Transcriptomics, and Proteomics of Psoriasis and Psoriatic Arthritis in Monozygotic Twins

Angela Ceribelli1, Elvezia Maria Paraboschi2, Natasa Isailovic1, Elena Generali1, Michela Robusto2, Maria De Santis1, Giulia Cardamone2, Francesco Sacrini3, Antonio Costanzo3, Stefano Duga2 and Carlo Selmi1, 1Rheumatology and Clinical Immunology, Humanitas Research Hospital, Rozzano (MI), Italy, 2Laboratory of Medical genetics and RNA biology, Humanitas Research Hospital, Rozzano, Italy, 3Dermatology Unit, Humanitas Research Hospital, Rozzano, Italy

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Methylation and proteomics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Psoriatic disease is a chronic inflammatory disorder spanning from skin disease (PsO) to psoriatic arthritis (PsA) without known serum biomarkers. The genetic background is insufficient to explain disease onset as illustrated by monozygotic (MZ) twins and epigenetics may contribute to disease susceptibility modulating gene expression. We analyzed the DNA methylation, transcriptome, and proteomic profile in MZ twins discordant for PsO/PsA.

Methods: MZ twin couples discordant and concordant for PsO/PsA were investigated for (1) genome-wide DNA methylation (Infinium MethylationEPIC BeadChip), (2) RNA and transcriptome (Illumina TruSeq Stranded mRNA kit), and (3) proteomics using aptamers (SOMAlogic).Results observed with aptamers were further validated by ELISA.

Results: The epigenetic analysis identified 19 genes consistently differentially methylated and mostly involved in the pathway of TGF-β and IFN response. Pathway analysis of integrated DNA methylation and transcriptome demonstrated an enrichment in “transcription regulation”, “innate immunity”, “ATP-binding” and, “Srp-dependent co-translational proteins”, that may be involved in the psoriatic condition. Serum proteomics reported a significant up- and downregulation of 10 and 3 proteins, respectively, largely involved in the innate and adaptive immune response, DNA repair and DNA damage sensors. Validation results showed a significant correlation between the SOMAlogic and ELISA tests for 2 proteins (respectively r=0.70, p=0.02, and r=0.50, p=0.04) and we confirmed that levels of 3 proteins involved in the regulation of UV radiation-induced apoptosis and in the cutaneous inflammatory response were elevated in sera from psoriatic disease patients, albeit not significantly, and one protein involved in hematopoietic and dendritic cell differentiation and apoptosis was significantly more expressed in both Pso and PsA compared to controls (HC n=2, 20%, Pso+PsA n=18, 60%, p=0.028; Pso n=10, 66.7%, p=0.02).

Conclusion: We report the first -omics approach in MZ twins discordant for psoriatic disease and suggest that the observed changes may constitute diasease biomarkers and point to biological pathways with a potential pathogenic role.


Disclosure: A. Ceribelli, None; E. M. Paraboschi, None; N. Isailovic, None; E. Generali, None; M. Robusto, None; M. De Santis, None; G. Cardamone, None; F. Sacrini, None; A. Costanzo, None; S. Duga, None; C. Selmi, None.

To cite this abstract in AMA style:

Ceribelli A, Paraboschi EM, Isailovic N, Generali E, Robusto M, De Santis M, Cardamone G, Sacrini F, Costanzo A, Duga S, Selmi C. Genome-Wide DNA Methylation, Transcriptomics, and Proteomics of Psoriasis and Psoriatic Arthritis in Monozygotic Twins [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/genome-wide-dna-methylation-transcriptomics-and-proteomics-of-psoriasis-and-psoriatic-arthritis-in-monozygotic-twins/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genome-wide-dna-methylation-transcriptomics-and-proteomics-of-psoriasis-and-psoriatic-arthritis-in-monozygotic-twins/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology